Inato grabs $14 mn

Paris-based Inato, a platform that helps biopharmaceutical companies increase the pool of available patients engaged in clinical trials, has raised $14 million in Series A financing.

Paris-based Inato, a platform that helps biopharmaceutical companies increase the pool of available patients engaged in clinical trials, has raised $14 million in Series A financing. Obvious Ventures and Cathay Innovation led the round with participation from return backers Serena and Fly Ventures.

Source: Press Release